A K Gopal, S M Schuetze, D G Maloney, P L Weiden. Show Affiliations »
Abstract
Entities: Disease Species
Mesh： See more » Antigens, CD/analysisAntineoplastic Combined Chemotherapy Protocols/therapeutic useBone Marrow/pathologyCombined Modality TherapyCyclophosphamide/administration & dosageDoxorubicin/administration & dosageHodgkin Disease/drug therapyHodgkin Disease/immunologyHodgkin Disease/pathologyHumansImmunohistochemistryLeukemia, Lymphocytic, Chronic, B-Cell/drug therapyLeukemia, Lymphocytic, Chronic, B-Cell/immunologyLeukemia, Lymphocytic, Chronic, B-Cell/pathologyLymphoma, Large B-Cell, Diffuse/drug therapyLymphoma, Large B-Cell, Diffuse/immunologyLymphoma, Large B-Cell, Diffuse/pathologyMaleMiddle AgedNeoplasms, Second Primary/drug therapyNeoplasms, Second Primary/immunologyNeoplasms, Second Primary/pathologyPrednisone/administration & dosageVincristine/administration & dosage
Substances： See more » Antigens, CDVincristineDoxorubicinCyclophosphamidePrednisone
Year: 1999 PMID： 10576806
Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113